Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine

Bergamin, 2007, Porcine B-cell activating factor promotes anti-FMDV antibodies in vitro but not in vivo after DNA vaccination of pigs, Vet. Immunol. Immunopathol., 120, 115, 10.1016/j.vetimm.2007.06.021 Borrego, 2006, DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses, Vaccine, 24, 3889, 10.1016/j.vaccine.2006.02.028 Cedillo-Barrón, 2001, Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase, J. Gen. Virol., 82, 1713, 10.1099/0022-1317-82-7-1713 Cedillo-Barrón, 2003, Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine, Vaccine, 21, 4261, 10.1016/S0264-410X(03)00453-5 Chen, 2006, Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease, Vet. Immunol. Immunopathol., 109, 177, 10.1016/j.vetimm.2005.08.028 Chénard, 2003, A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology, J. Virol. Methods, 107, 89, 10.1016/S0166-0934(02)00196-9 Cox, 2003, Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines, Vaccine, 21, 1336, 10.1016/S0264-410X(02)00691-6 Dory, 2005, Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins, Vaccine, 23, 3483, 10.1016/j.vaccine.2004.10.050 Du, 2007, Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor, Vaccine, 25, 8209, 10.1016/j.vaccine.2007.09.062 Dubensky, 1996, Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer, J. Virol., 70, 508, 10.1128/JVI.70.1.508-519.1996 Dufour, 2000, Induction of porcine cytokine mRNA expression after DNA immunization and pseudorabies virus infection, J. Interferon Cytokine Res., 20, 889, 10.1089/10799900050163262 Fan, 2007, Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus, Virus Genes, 35, 347, 10.1007/s11262-007-0105-0 Gravier, 2007, In vivo tissue distribution and kinetics of a pseudorabies virus plasmid DNA vaccine after intramuscular injection in swine, Vaccine, 25, 6930, 10.1016/j.vaccine.2007.07.001 Grubman, 2004, Foot-and-mouth disease, Clin. Microbiol. Rev., 17, 465, 10.1128/CMR.17.2.465-493.2004 Guo, 2005, Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99, Vaccine, 23, 3236, 10.1016/j.vaccine.2004.03.074 Guo, 2004, The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus, Acta Biochim. Biophys. Sin. (Shanghai), 36, 701, 10.1093/abbs/36.10.701 Hahn, 2004, Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination, Int. J. Med. Microbiol., 294, 35, 10.1016/j.ijmm.2003.12.002 Hariharan, 1998, DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector, J. Virol., 72, 950, 10.1128/JVI.72.2.950-958.1998 Kim, 2006, DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity, J. Gene Med., 8, 1182, 10.1002/jgm.941 King, 1981, Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK, Nature, 293, 479, 10.1038/293479a0 Kirman, 2003, Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A, Infect. Immun., 71, 575, 10.1128/IAI.71.1.575-579.2003 Leitner, 2000, Enhancement of tumor-specific immune response with plasmid DNA replicon vectors, Cancer Res., 60, 51 Leitner, 1999, DNA and RNA-based vaccines: principles, progress and prospects, Vaccine, 18, 765, 10.1016/S0264-410X(99)00271-6 Li, 2006, Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O, Vaccine, 24, 4602, 10.1016/j.vaccine.2005.08.032 Loizel, 2005, Effect of granulocyte-macrophage colony-stimulating factor on post-weaning multisystemic wasting syndrome in porcine circovirus type-2-transfected piglets, Int. J. Exp. Pathol., 86, 33, 10.1111/j.0959-9673.2005.00409.x Mann, 1947, On a test of whether one of two random variables is stochastically larger than the other, Ann. Math. Stat., 18, 50, 10.1214/aoms/1177730491 Mingxiao, 2007, Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18, Antiviral Res., 76, 59, 10.1016/j.antiviral.2007.05.003 Niborski, 2006, Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV, Vaccine, 24, 7204, 10.1016/j.vaccine.2006.06.048 OIE, 2000. OIE Manual of Standards for diagnostics tests and vaccines, fourth edition. Park, 2006, Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes, J. Vet. Sci., 7, 257, 10.4142/jvs.2006.7.3.257 Peachman, 2003, Immunization with DNA through the skin, Methods, 31, 232, 10.1016/S1046-2023(03)00137-3 Raz, 1994, Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses, Proc. Natl. Acad. Sci. U.S.A., 91, 9519, 10.1073/pnas.91.20.9519 Rodrigo, 1995, Evolutionary analysis of the picornavirus family, J. Mol. Evol., 40, 362, 10.1007/BF00164022 Ryan, 1989, Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing, Virology, 173, 35, 10.1016/0042-6822(89)90219-5 Serafini, 2004, High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells, Cancer Res., 64, 6337, 10.1158/0008-5472.CAN-04-0757 Sobrino, 2001, Foot-and-mouth disease virus: a long known virus, but a current threat, Vet. Res., 32, 1, 10.1051/vetres:2001106 Somasundaram, 1999, Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus, Vet. Immunol. Immunopathol., 70, 277, 10.1016/S0165-2427(99)00085-9 Stellmann, 1989, The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement, J. Biol. Stand., 17, 17, 10.1016/0092-1157(89)90024-3 The Veterinary Record, 2007, FMD outbreak linked to defective drain, Vet. Rec., 161, 362, 10.1136/vr.161.11.362 Wong, 2002, A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2, Vaccine, 20, 2641, 10.1016/S0264-410X(02)00212-8 Xiao, 2007, Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants, Antiviral Res., 76, 11, 10.1016/j.antiviral.2007.04.002 Yin, 2005, Investigations of the effect of DNA size in transient transfection assay using dual luciferase system, Anal. Biochem., 346, 289, 10.1016/j.ab.2005.08.029 Zhang, 2003, Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus, Vaccine, 21, 4704, 10.1016/S0264-410X(03)00519-X Zhu, 2004, DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment, Vaccine, 22, 660, 10.1016/j.vaccine.2003.08.036